{"nct_id":"NCT01029652","title":"Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study","status":"COMPLETED","status_verified_date":"2012-09","start_date":"2009-12","start_date_type":null,"primary_completion_date":"2010-10","primary_completion_date_type":"ACTUAL","completion_date":"2010-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}